Corinne Johnson
Stock Analyst at Goldman Sachs
(0.27)
# 4,077
Out of 4,786 analysts
7
Total ratings
16.67%
Success rate
-14.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $29.52 | +99.86% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $18.49 | +105.52% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $24.49 | +104.16% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $17.09 | +192.57% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $29.52
Upside: +99.86%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $18.49
Upside: +105.52%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $24.49
Upside: +104.16%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $17.09
Upside: +192.57%